Immunosuppression and Psoriasis

Summary:

Psoriasis is found among people with Immunosuppression, especially for people who are female, 50-59 old.

The study analyzes which people have Psoriasis with Immunosuppression. It is created by eHealthMe based on reports of 18 people who have Immunosuppression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 08, 2022

18 people who have Immunosuppression and Psoriasis are studied.


What is Immunosuppression?

Immunosuppression is found to be associated with 1,308 drugs and 848 conditions by eHealthMe.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 2,260 drugs and 1,579 conditions by eHealthMe.

Number of Psoriasis in Immunosuppression reports submitted per year:

Would you have Psoriasis when you have Immunosuppression?

Gender of people who have Immunosuppression and experienced Psoriasis *:

  • female: 70 %
  • male: 30 %

Age of people who have Immunosuppression and experienced Psoriasis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 16.67 %
  • 30-39: 0.0 %
  • 40-49: 16.67 %
  • 50-59: 66.67 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Hepatitis C: 6 people, 33.33%
  2. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 11.11%
  3. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 1 person, 5.56%
  4. Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 5.56%
  5. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 1 person, 5.56%
  6. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 5.56%
  7. Birth Control: 1 person, 5.56%

Common drugs taken by these people *:

  1. Sofosbuvir: 5 people, 27.78%
  2. Everolimus: 4 people, 22.22%
  3. Methylprednisolone: 2 people, 11.11%
  4. Tacrolimus: 2 people, 11.11%
  5. Prednisolone: 2 people, 11.11%
  6. Methotrexate: 2 people, 11.11%
  7. Vancomycin: 1 person, 5.56%
  8. Cosentyx: 1 person, 5.56%
  9. Enbrel: 1 person, 5.56%
  10. Humira: 1 person, 5.56%

Common symptoms for these people *:

  1. Infection: 8 people, 44.44%
  2. Thrombocytopenia (decrease of platelets in blood): 7 people, 38.89%
  3. Pneumonia: 6 people, 33.33%
  4. Urinary Tract Infection: 6 people, 33.33%
  5. High Blood Pressure: 5 people, 27.78%
  6. Cardiac Failure: 5 people, 27.78%
  7. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 5 people, 27.78%
  8. Malnutrition (condition that results from eating a diet in which certain nutrients are lacking): 5 people, 27.78%
  9. Ascites (accumulation of fluid in the abdominal cavity): 5 people, 27.78%
  10. Leukopenia (less number of white blood cells in blood): 5 people, 27.78%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Psoriasis?

Check whether Psoriasis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Psoriasis:

Common drugs associated with Psoriasis:

All the drugs that are associated with Psoriasis:

Common conditions associated with Psoriasis:

All the conditions that are associated with Psoriasis:

How the study uses the data?

The study is based on Psoriasis and Immunosuppression, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: